(Q66963091)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:501816%20AND%20SRC:MED&resulttype=core&format=json

1 September 2019

title

Cyclophosphamide, doxorubicin hydrochloride and 5-fluorouracil in advanced carcinoma of the prostate (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:501816%20AND%20SRC:MED&resulttype=core&format=json

1 September 2019

Cyclophosphamide, Doxorubicin Hydrochloride and 5-Fluorouracil in Advanced Carcinoma of the Prostate (English)

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)56538-6

13 June 2023

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)56538-6

13 June 2023

author name string

M. S. Soloway

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A501816

7 July 2022

R. M. Shippel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A501816

7 July 2022

M. Ikard

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A501816

7 July 2022

language of work or name

English

0 references

publication date

1 November 1979

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:501816%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

1 September 2019

https://api.elsevier.com/content/article/PII:S0022534717565386?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)56538-6

https://api.elsevier.com/content/article/PII:S0022534717565386?httpAccept=text/plain

13 June 2023

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)56538-6

http://www.jurology.com/doi/pdf/10.1016/S0022-5347%2817%2956538-6

13 June 2023

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)56538-6

13 June 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:501816%20AND%20SRC:MED&resulttype=core&format=json

1 September 2019

volume

122

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:501816%20AND%20SRC:MED&resulttype=core&format=json

1 September 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:501816%20AND%20SRC:MED&resulttype=core&format=json

1 September 2019

page(s)

637-639

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:501816%20AND%20SRC:MED&resulttype=core&format=json

Chemotherapy of Advanced Prostatic Carcinoma with Cyclophosphamide or 5-Fluorouracil: Results of First National Randomized Study

1 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)56538-6

The continued evaluation of the effects of chemotherapy in patients with advanced carcinoma of the prostate

13 June 2023

2

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)56538-6

National randomized study of chemotherapeutic agents in advanced prostatic carcinoma: a progress report

13 June 2023

3

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)56538-6

Multiple drug chemotherapy regimen for patients with hormonally-unresponsive carcinoma of the prostate: a preliminary report

13 June 2023

6

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)56538-6

Chemotherapy of Advanced Carcinoma of the Prostate with 5-Fluorouracil, Cyclophosphamide and Adriamycin

13 June 2023

7

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)56538-6

13 June 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:501816%20AND%20SRC:MED&resulttype=core&format=json

1 September 2019

1 reference